Taking stock of the drug industry, from the lab to the medicine chestMay 12, 2023Check out STAT+Sponsored ByBy Ed SilvermanPharmalot Columnist, Senior Writer Kristoffer Tripplaar/Sipa via AP STAT+ | Tracking the FDA advisory panel on Sarepta's gene therapy for Duchenne muscular dystrophy We'll be watching a livestream of the FDA advisory meeting on Sarepta's therapy and writing frequent updates and analysis throughout the day. By Adam Feuerstein and Jason Mast From fusion to retooling cancer trials, Eric Lander wants his new group to 'go after big problems' "I think it cuts to the heart of what scientists want to do, which is to go after big problems," Eric Lander told STAT. By Megan Molteni STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Nicholas Florko/STAT R.J. Reynolds sues California to protect 'crisp' cigarettes from flavor ban Tobacco giant R.J. Reynolds is suing the state of California in an effort to keep a controversial new line of cigarettes on shelves. By Nicholas Florko Opinion: Proposed rules to protect health data in an era of abortion bans fall short In current form, the rules fail to help the people who need them most: those who live in states with abortion travel bans. By Eric D. Perakslis and Katie D. McMillan and Jessilyn Dunn More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments